Wells Fargo & Company »

Plus Therapeutics shares owned by Wells Fargo & Company

Quarter-by-quarter ownership of Plus Therapeutics (PSTV) shares owned by Wells Fargo & Company from 13F filings

Historical chart of Wells Fargo & Company investment in Plus Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Plus Therapeutics held by Wells Fargo & Company consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Plus Therapeutics by Wells Fargo & Company

Quarter filed Position value Share count Share price at filing
2025-09-30 $35 53 0.68
2025-06-30 $123 357 0.35
2024-03-31 $63 35 1.80
2023-12-31 $61 35 1.74
2023-09-30 $27 21 1.33
2023-06-30 $36 18 2.00